House Republicans subpeona 8 health insurers over ACA fraud
Rebecca Pifer Parduhn / healthcaredive - The subpoenas request additional documents and information from CVS, Centene, Elevance and more, and suggest House Republicans are considering legislation to combat what they view as rampant fraud in the ACA exchanges.
AI Summary: A House committee issued subpoenas to eight major insurers seeking documents related to suspected fraud in ACA marketplace subsidies. The probes target several large payers and escalate congressional scrutiny of insurance enrollment and subsidy integrity, promising political theater and maybe some procedural headaches.
Nisha Morris Joins Executive Leadership Team as Senior Vice President – City of Hope
oncodaily - City of Hope shared a post on LinkedIn: “We are pleased to announce that Nisha Morris has been appointed Senior Vice President and Chief Marketing and Communications Officer at City […]
AI Summary: City of Hope named Nisha Morris as Senior Vice President and Chief Marketing and Communications Officer, adding marketing leadership to its executive team. The move signals a renewed focus on brand, outreach, and patient engagement as the cancer center sharpens its communication and growth strategies.
CMS proposes sweeping ACA exchange rule
Emily Olsen / healthcaredive - The CMS said the regulation should remove barriers to more affordable health plans, like catastrophic coverage, as enrollment on the exchanges falls following the expiration of stronger financial assistance.
AI Summary: CMS has proposed a major rule reshaping Affordable Care Act marketplace policies, including loosening limits on non-standard plan designs and promoting lower-premium options such as catastrophic coverage. The agency says the changes will reduce costs and boost flexibility, while critics warn they could increase confusion and weaken consumer protections—because shopping for insurance clearly wasn’t complicated enough.
Tenet expects 20% ACA enrollment drop
Alan Condon / beckershospitalreview - Dallas-based Tenet Healthcare expects a 20% reduction in ACA exchange enrollment this year with the expiration of enhanced premium tax credits set to pressure hospital earnings and payer mix. The company is projecting adjusted EBITDA of up to $4.8 billion…
AI Summary: Tenet Healthcare is warning that the expiration of enhanced Affordable Care Act premium tax credits will drive a steep reduction in ACA exchange enrollment, projecting a significant revenue impact in 2026. Despite the headwind, the company says it expects earnings growth, leaning on acuity and operational performance—because nothing calms Wall Street like “we’ll make it up somewhere else.”
FDA refuses to review Moderna flu vaccine
Ella Jeffries / beckershospitalreview - Moderna has received a refusal-to-file letter from the FDA’s Center for Biologics Evaluation and Research for its biologics license application for mRNA-1010, its investigational seasonal influenza vaccine. The letter, signed by Vinayak Prasad, MD, chief …
AI Summary: Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making.
AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelo
Anna Brown / endpoints - The FDA has handed AstraZeneca a complete response letter for the subcutaneous prefilled, self-injectable pen of Saphnelo for systemic lupus erythematosus (SLE), a month after the asset gained approval in Europe ...
AI Summary: AstraZeneca’s application to market its subcutaneous prefilled pen formulation of Saphnelo for treating lupus has hit a roadblock after the FDA issued a complete response letter. The decision delays the drug’s approval and raises questions about its future in the competitive immunotherapy market.
Public Health Department confirms first 2026 measles case in Los Angeles County
medicalxpress - The Department of Public Health has confirmed the first measles case this year in Los Angeles County. Officials say the person who tested positive for measles had recently traveled outside the country. The department is now working to identify people who …
AI Summary: Los Angeles County health officials confirmed the first measles case of 2026 even as nationwide data reveal that only one month into the year, case numbers have already reached 25% of 2025’s total. Experts warn that if vaccination rates do not improve promptly, an early outbreak could expand and stress public health systems.
World Cancer Day: A Global Call to Awareness and Action 2026, Part 2
oncodaily - World Cancer Day is observed annually on February 4 and was established in 2000 at the World Summit Against Cancer for the New Millennium in Paris. The initiative was led […]
AI Summary: World Cancer Day 2026, observed on February 4, serves as a global rallying cry to boost cancer awareness, promote early detection, and improve patient access to care. Healthcare professionals, advocates, and patients united at the event to spotlight the critical need for innovation and coordinated action against cancer.
- Early Detection & Access Initiatives (4)
- Other Cancer News (15)
- Research and Treatment Advances (28)
- World Cancer Day Global Events (4)
- All Other Stories
Early Detection & Access Initiatives
Other Cancer News
Research and Treatment Advances
World Cancer Day Global Events
All Other Stories
HHS launches $100M homelessness, addiction treatment initiative
Ella Ruder / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. unveiled a $100 million federal initiative to address homelessness, opioid addiction and public safety following President Donald Trump’s executive order creating the Great American Recovery Initiative. The Safety Throu…
AI Summary: Two nearly identical reports detail a new federal announcement by HHS, which unveiled a $100M initiative aimed at tackling homelessness among individuals with addiction issues. The program is designed to integrate mental health, addiction treatment, and social services to rapidly stabilize vulnerable populations.
MultiCare agrees to $3.7M settlement over allegations it knowingly allowed unnecessary surgeries
fiercehealthcare - The DOJ said MultiCare had allowed a former physician to perform spinal surgery procedures at its facilities between 2019 and 2021 despite warnings from two employees and the U.S. Attorney's Office.
AI Summary: Federal investigators found that MultiCare knowingly allowed a former physician to perform unnecessary spinal surgeries despite multiple warnings, prompting a whistleblower lawsuit. In response, the health system agreed to a $3.7 million settlement to resolve the allegations and avoid further litigation.
HHS to drop 340B rebate pilot after court rulings
Ella Jeffries / beckershospitalreview - HHS will drop its 340B rebate model pilot program following two federal court rulings that blocked its implementation. The program, announced in August 2025, was challenged by the American Hospital Association, the Maine Hospital Association and four safe…
AI Summary: In a twist that no one saw coming (except the federal courts), HHS has scrapped its controversial 340B rebate pilot after two judicial rulings blocked its implementation. Providers, relieved to avoid a potential cash flow nightmare, are quietly celebrating the decision as one less bureaucratic headache to manage.
#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
Ayisha Sharma / endpoints - Bayer shared more details from its unexpected win in a Phase 3 study testing its next-generation blood thinner for secondary stroke prevention. The factor XIa inhibitor, named asundexian, reduced the occurrence of ischemic stroke by ...
AI Summary: Bayer’s latest Phase 3 study of asundexian has shown a 26% reduction in secondary ischemic stroke risk—without an increased bleeding risk. This compelling data bolsters the drug’s prospects as a blockbuster in stroke prevention and underscores Bayer’s commitment to advancing cardiovascular therapies.
AI model reads brain MRIs in seconds, hitting up to 97.5% accuracy
medicalxpress - An AI-powered model developed at the University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests. The model detected neurological conditions with up to 97.5% accuracy and predicted how urgently a patient required treatme…
AI Summary: Researchers at the University of Michigan have unveiled an AI-powered model that reads brain MRIs in seconds with up to 97.5% accuracy. This breakthrough promises to ease radiologist workloads and dramatically speed up neurodiagnostics, potentially transforming clinical workflows in imaging.
Eikon Therapeutics Raises $381 M in IPO to Advance Live-Cell Imaging in Cancer Drug Discovery
oncodaily - Eikon Therapeutics has raised $381 million through its IPO, pricing at the top of its range in a strong sign of renewed investor appetite for biotech offerings. The South San […]
AI Summary: Eikon Therapeutics successfully raised $381 million in its IPO, reinforcing investor confidence in novel biotechnology approaches for cancer drug discovery. The fundraising milestone is expected to accelerate live‐cell imaging and other innovative oncology research initiatives.
High Consumption of Ultraprocessed Foods May Be Linked to Cancer Survivors’ Risk of Death
Kathleen Medora / aacr - PHILADELPHIA – Cancer survivors who consumed higher amounts of ultraprocessed foods as part of their diet had a significantly increased risk of both all-cause and cancer-specific death, according to a study published in Cancer Epidemiology, Biomarkers & P…
AI Summary: Recent research from a Philadelphia‐based study indicates that cancer survivors consuming high amounts of ultraprocessed foods face significantly increased risks of both overall and cancer‐specific death. Experts stress that optimizing diet post‐treatment is critical for improving long‐term outcomes.
Epic rolls out AI Charting tool
Naomi Diaz / beckershospitalreview - Epic has rolled out AI Charting, a built-in tool that listens during patient visits and drafts clinicians’ notes and suggested orders in real time. The feature is part of Epic’s expanding set of AI capabilities built directly into its software, according …
AI Summary: Epic has launched an integrated AI–powered charting tool designed to automate note–taking and suggest orders during patient visits, a strategic move aimed at reducing documentation burden and streamlining clinical workflow in a competitive ambient scribe market.
A newborn's death likely linked to the mom drinking raw milk while pregnant
go - Health officials in New Mexico have said a newborn baby died from a listeria infection likely linked to the child's mother drinking raw milk during pregnancy
AI Summary: New Mexico health officials report a tragic newborn death attributed to a listeria infection linked to the mother’s consumption of unpasteurized raw milk during pregnancy, re–igniting long–standing concerns about food safety standards and the risks involved in consuming unregulated dairy products.
HHS scraps 340B rebate pilot in win for hospitals
Emily Olsen / healthcaredive - The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.
AI Summary: Federal health officials have reversed course on a highly controversial 340B rebate pilot program after federal courts blocked its implementation – a move hailed by providers as a long‐awaited relief from cash flow and administrative burdens.
Statin pills much safer than advertised, major review finds
bbc - The results, in The Lancet journal, come from trials involving more than 120,000 people comparing statins with a dummy drug or placebo.
AI Summary: Multiple large‐scale analyses have debunked the long‐held worries about statin side effects – it turns out that those pesky symptoms listed on package leaflets are no more common than when taking a placebo. In other words, patients can keep calm and lower cholesterol with confidence.
Novo Nordisk vows legal action to protect Wegovy pill
medicalxpress - Novo Nordisk said Thursday it would take legal action against a US chain offering a copycat of the new pill version of its Wegovy weight-loss drug.
AI Summary: Novo Nordisk has vowed to take legal action after discovering that competitors – including Hims & Hers – plan to market a compounded, lower‐priced version of its new Wegovy weight‐loss pill. The company is mobilizing its legal team to protect its intellectual property amid fierce market competition.